サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1742538

急性腎障害治療市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測

Acute Kidney Injury Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 199 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
急性腎障害治療市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測
出版日: 2025年04月11日
発行: Transparency Market Research
ページ情報: 英文 199 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

急性腎障害治療市場- 調査範囲

TMRの調査レポート「急性腎障害治療の世界市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019～2035年までの世界の急性腎障害治療市場の収益と予測を提供します。また、2025～2035年までの世界の急性腎障害治療市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、急性腎障害治療市場を推察しました。

市場スナップショット
2024年の市場規模 36億米ドル
2035年の市場規模 82億米ドル
CAGR 7.8%

当レポートでは、世界の急性腎障害治療市場の競合情勢について調査しています。世界の急性腎障害治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の急性腎障害治療市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の急性腎障害治療市場分析と予測、2020～2035年

第5章 主要洞察

  • パイプライン分析
  • 主要製品とブランドの分析
  • 国/地域別の規制シナリオ
  • 主要国における世界の疾病罹患率と発症率
  • AKIタイプ別の死亡率- 世界と主要国
  • 新たな動向-AKIタイプ別
    • 治験薬（IND）-MTX652
    • iNPC由来細胞外小胞（EV）を用いたAKIに対するEV療法
    • 急性腎障害（AKI）の早期診断のためのバイオマーカー
    • 持続的腎代替療法（CRRT）の進歩
    • 腎臓修復における遺伝子治療
    • シラスタチンによるネフロトキシン誘発性急性腎障害の予防
    • AKI治療薬候補-UNI-494
    • RMC-035-IND（治験薬）
    • AKIにおける人工知能
    • 間葉系幹細胞療法
  • 競合が提供する製品のベンチマーク
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 新規参入企業（主にOEM）の制約・課題と考慮すべき主な要因およびビジネスモデルに関する洞察

第6章 世界の市場分析と予測：薬物療法別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：薬物療法別、2020～2035年
    • 血管収縮薬
    • 強心薬
    • 利尿剤
    • 静脈内（IV）晶質液
    • 免疫抑制薬
    • その他
  • 市場の魅力：薬物療法別

第7章 世界の市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：タイプ別、2020～2035年
    • 腎前性急性腎障害
    • 内因性腎急性腎障害
    • 腎後性急性腎障害
  • 市場の魅力：タイプ別

第8章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：流通チャネル別、2020～2035年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力：流通チャネル別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカ地域の市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析企業別（2024）
  • 企業プロファイル
    • AM-Pharma
    • Aptabio Therapeutics
    • Arch Biopartners
    • Novartis AG
    • Guard Therapeutics
    • Renibus Therapeutics
    • Mission Therapeutics
    • Unicycive Therapeutics Inc.
    • Baxter International Inc.
    • ICU Medical
    • B. Braun Melsungen AG
    • Fresenius Kabi
    • Amanta Healthcare
    • Pfizer, Inc.
    • Sanofi S.A.
図表

List of Tables

  • Table 01: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 02: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 03: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 07: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 08: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 10: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 11: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 12: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 15: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 16: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 19: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 20: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Drug Therapy, 2020-2035
  • Table 23: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 24: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 03: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 04: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Vasoconstrictor Agents, 2020-2035
  • Figure 05: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Inotropic Drugs, 2020-2035
  • Figure 06: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Diuretics, 2020-2035
  • Figure 07: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Intravenous (IV) Crystalloid Solution, 2020-2035
  • Figure 08: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Immunosuppressive Drugs, 2020-2035
  • Figure 09: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by others, 2020-2035
  • Figure 10: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 11: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 12: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Pre-renal Acute Kidney Injury, 2020-2035
  • Figure 13: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Intrinsic renal Acute Kidney Injury, 2020-2035
  • Figure 14: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Post-renal Acute Kidney Injury, 2020-2035
  • Figure 15: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 16: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 17: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 18: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 19: Global Acute Kidney Injury Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
  • Figure 20: Global Acute Kidney Injury Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 22: North America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 23: North America - Acute Kidney Injury Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 25: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 26: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 27: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 27: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 29: North America - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 30: North America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 31: Europe - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 32: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 33: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 34: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 35: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 36: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 37: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 38: Europe - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 39: Europe - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 40: Asia Pacific - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 41: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 42: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 43: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 44: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 45: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 46: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 47: Asia Pacific - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 48: Asia Pacific - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 49: Latin America - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 50: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 51: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 52: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 53: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 54: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 55: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 56: Latin America - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 57: Latin America - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 58: Middle East & Africa - Acute Kidney Injury Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 61: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Drug Therapy, 2024 and 2035
  • Figure 62: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Drug Therapy, 2025-2035
  • Figure 63: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 64: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 65: Middle East & Africa - Acute Kidney Injury Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Middle East & Africa - Acute Kidney Injury Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
目次
Product Code: TMRGL67523

Acute Kidney Injury Treatment Market - Scope of Report

TMR's report on the global acute kidney injury treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global acute kidney injury treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute kidney injury treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the acute kidney injury treatment market.

Market Snapshot
Market Value in 2024US$ 3.6 Bn
Market Value in 2035US$ 8.2 Bn
CAGR7.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute kidney injury treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global acute kidney injury treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute kidney injury treatment market.

The report delves into the competitive landscape of the global acute kidney injury treatment market. Key players operating in the global acute kidney injury treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global acute kidney injury treatment market profiled in this report.

Key Questions Answered in global acute kidney injury treatment Market Report:

  • What is the sales/revenue generated by acute kidney injury treatment across all regions during the forecast period?
  • What are the opportunities in the global acute kidney injury treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Acute Kidney Injury Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global acute kidney injury treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global acute kidney injury treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global acute kidney injury treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Acute Kidney Injury Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product & Brand Analysis
  • 5.3. Regulatory Scenario by Country/Region
  • 5.4. Disease Prevalence & Incidence Rate globally with key countries
  • 5.5. Mortality Rate by Type of AKI- globally with key Countries
  • 5.6. Emerging Trends - By Type of AKI
    • 5.6.1. Investigational New Drug (IND) - MTX652
    • 5.6.2. Extracellular Vesicle (EV) Therapy for AKI using iNPC-derived EV
    • 5.6.3. Biomarkers for Early AKI Diagnosis
    • 5.6.4. Continuous Renal Replacement Therapy (CRRT) Advancements
    • 5.6.5. Gene Therapy in Kidney Repair
    • 5.6.6. Prevention Of NephroToxin induced Acute Kidney injury with Cilastatin
    • 5.6.7. Drug Candidate For the Treatment of AKI - UNI-494
    • 5.6.8. RMC-035-IND (Investigational New Drug)
    • 5.6.9. Artificial Intelligence in AKI
    • 5.6.10. Mesenchymal Stem Cell Therapy
  • 5.7. Benchmarking of the Products Offered by the Competitors
  • 5.8. Porter's Five Forces Analysis
  • 5.9. PESTEL Analysis
  • 5.10. Insights on Restraints/Challenges & Major Factors for Considerations & Business Models for New Entrants (Mainly OEMs)

6. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Drug Therapy

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Therapy, 2020-2035
    • 6.3.1. Vasoconstrictor Agents
    • 6.3.2. Inotropic Drugs
    • 6.3.3. Diuretics
    • 6.3.4. Intravenous (IV) Crystalloid Solution
    • 6.3.5. Immunosuppressive Drugs
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Drug Therapy

7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Type, 2020-2035
    • 7.3.1. Pre-renal Acute Kidney Injury
    • 7.3.2. Intrinsic renal Acute Kidney Injury
    • 7.3.3. Post-renal Acute Kidney Injury
  • 7.4. Market Attractiveness By Type

8. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Acute Kidney Injury Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 10.2.1. Vasoconstrictor Agents
    • 10.2.2. Inotropic Drugs
    • 10.2.3. Diuretics
    • 10.2.4. Intravenous (IV) Crystalloid Solution
    • 10.2.5. Immunosuppressive Drugs
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Type, 2020-2035
    • 10.3.1. Pre-renal Acute Kidney Injury
    • 10.3.2. Intrinsic renal Acute Kidney Injury
    • 10.3.3. Post-renal Acute Kidney Injury
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Therapy
    • 10.6.2. By Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Acute Kidney Injury Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 11.2.1. Vasoconstrictor Agents
    • 11.2.2. Inotropic Drugs
    • 11.2.3. Diuretics
    • 11.2.4. Intravenous (IV) Crystalloid Solution
    • 11.2.5. Immunosuppressive Drugs
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Type, 2020-2035
    • 11.3.1. Pre-renal Acute Kidney Injury
    • 11.3.2. Intrinsic renal Acute Kidney Injury
    • 11.3.3. Post-renal Acute Kidney Injury
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Therapy
    • 11.6.2. By Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Acute Kidney Injury Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 12.2.1. Vasoconstrictor Agents
    • 12.2.2. Inotropic Drugs
    • 12.2.3. Diuretics
    • 12.2.4. Intravenous (IV) Crystalloid Solution
    • 12.2.5. Immunosuppressive Drugs
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Type, 2020-2035
    • 12.3.1. Pre-renal Acute Kidney Injury
    • 12.3.2. Intrinsic renal Acute Kidney Injury
    • 12.3.3. Post-renal Acute Kidney Injury
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Therapy
    • 12.6.2. By Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country / Sub-region

13. Latin America Acute Kidney Injury Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 13.2.1. Vasoconstrictor Agents
    • 13.2.2. Inotropic Drugs
    • 13.2.3. Diuretics
    • 13.2.4. Intravenous (IV) Crystalloid Solution
    • 13.2.5. Immunosuppressive Drugs
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Type, 2020-2035
    • 13.3.1. Pre-renal Acute Kidney Injury
    • 13.3.2. Intrinsic renal Acute Kidney Injury
    • 13.3.3. Post-renal Acute Kidney Injury
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Therapy
    • 13.6.2. By Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Therapy, 2020-2035
    • 14.2.1. Vasoconstrictor Agents
    • 14.2.2. Inotropic Drugs
    • 14.2.3. Diuretics
    • 14.2.4. Intravenous (IV) Crystalloid Solution
    • 14.2.5. Immunosuppressive Drugs
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Type, 2020-2035
    • 14.3.1. Pre-renal Acute Kidney Injury
    • 14.3.2. Intrinsic renal Acute Kidney Injury
    • 14.3.3. Post-renal Acute Kidney Injury
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Therapy
    • 14.6.2. By Type
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. AM-Pharma
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Aptabio Therapeutics
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Arch Biopartners
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Novartis AG
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Guard Therapeutics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Renibus Therapeutics
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Mission Therapeutics
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Unicycive Therapeutics Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Baxter International Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. ICU Medical
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. B. Braun Melsungen AG
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Fresenius Kabi
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Amanta Healthcare
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pfizer, Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Financial Overview
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Sanofi S.A.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Financial Overview
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments